A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Open-label randomized crossover design study. 60 participants will be evaluated on Day 1 to
compare effects on stomach acid; 30 participants will continue treatment for 7 days and will
have repeat evaluations at Day 7.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Collaborators:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.
Treatments:
Omeprazole Omeprazole, sodium bicarbonate drug combination